Filter Results:
(1,000)
Show Results For
- All HBS Web
(1,000)
- People (4)
- News (260)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
Show Results For
- All HBS Web
(1,000)
- People (4)
- News (260)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
- 04 Oct 2016
- Blog Post
Why We Recruit: CVS Health
of health. Through its approximately 9,600 retail pharmacies under the CVS, Navarro and Longs Drugs brand names, more than 1,135 walk-in MinuteClinc locations, a leading pharmacy benefits manager with more than 75 million plan members, a... View Details
Keywords: Health Care
- 01 Dec 2018
- News
Raising the Barrio
recently been the headquarters of a drug dealer known as “Tarzan.” It was a symbolic gesture, Rodríguez Larreta acknowledges, but an important one. “Our biggest obstacle was the lack of credibility. For years, [residents] have had... View Details
Keywords: April White
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing View Details
Keywords: Carmen Nobel
- 01 Jun 2001
- News
Stephen M. Moret: A Campaign for Positive Change
low-cost HIV/AIDS drugs to Malawi. “I’m the guy who still can’t believe I got to go to school here.” After traveling around the world this fall, Moret will take a position in McKinsey’s Washington, D.C., office, where he hopes to spend... View Details
- 01 Mar 2007
- News
HBS Alums Help Jailhouse Entrepreneurs Go Straight
Like it or not, a drug dealer, for example, already knows a lot about what it takes to run a successful business. Teaching them passion is not something we have to do; what we teach them is how to go legit.” At HBS, several students are... View Details
- 24 Aug 2020
- Blog Post
My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort
that must be answered for drugs to make it to market. And I especially loved any chance I got to dive into the science behind these questions. A few years ago, as I started to think about what I wanted to do longer term, I toyed with the... View Details
- Profile
Arjun Goyal
“marries a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical... View Details
- Profile
Hunter Goble
scientists in Harvard and MIT’s ecosystem. Through a self-matching process that Hunter describes as “speed dating,” he found two scientists from Boston’s Children’s Hospital developing “a novel drug delivery platform that increases the... View Details
- 12 Apr 2018
- Op-Ed
Op-Ed: The Trouble with Tariffs
active ingredients for anti-nausea drugs, even the drug inside an EpiPen. There were also more mundane items like milking machine parts and telescopic gunsights for rifles. The careful selection avoided high-profile items like smartphones... View Details
Keywords: by Willy C. Shih; Manufacturing; Auto; Steel; Air Transportation; Technology; Telecommunications
- 01 Jan 2008
- News
Jeffrey R. Immelt, MBA 1982
protein biomarkers that have been identified as the precursor to Alzheimer’s disease. “There’s still no cure,” he observes, “but if you know that someone has the early signs of the disease and combine that with some of the new drugs the... View Details
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
invasive surgery, radiation, and chemotherapy for cancer, for example) with drugs that can palliate and perhaps cure genetically-linked diseases. But like most new technologies, these are hugely expensive to develop, and initially, to... View Details
- 01 Dec 2002
- News
Alumni Honorees Urge Students to Emphasize Ethics
2002 Alumni Achievement Awards Raymond V. Gilmartin (MBA '68) Chairman, President, and CEO, Merck & Co. Since June 1994, when Gilmartin became its president and CEO, Merck has launched seventeen new drugs and increased revenues from $15... View Details
- 01 Oct 1996
- News
Creating Miracles — Charles A. Coverdale (MBA 1971)
diabetes to support services for those with catastrophic illnesses such as AIDS. Through the church's efforts, hundreds of residents in Riverhead and beyond have been able to climb out of poverty, drug abuse, and crime to create lives of... View Details
Keywords: Marguerite Rigoglioso
- 01 Jun 2015
- News
Rebooting Europe
targeted effort to improve Ebola treatments resulted in development of an antiviral drug with potential to treat the early stages of the disease. Better research, Moedas says, also requires better support for researchers. At a gathering... View Details
- 01 Jun 2010
- News
Health IT at the Bedside
prescription from CVS and automatically check for any drug interactions. The hospital, like many community hospitals and doctors’ offices, did not have electronic records, but his office did. Would he ever go back to a paper prescription... View Details
- 01 Aug 2001
- News
Class Day and Commencement 2001
process at drug companies. Looking to the future and emphasizing that "there is no success in business that can compensate for failure at home," Clark told the Class of 2001, "You have the capacity to change the world, and you will touch... View Details
- 17 Oct 2006
- First Look
First Look: October 17, 2006
founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even shown a profit. No avalanche... View Details
Keywords: Sean Silverthorne
- 12 Jul 2006
- Research & Ideas
Competition the Cure for Healthcare
the various actors in the system are not designed around value, nor is competition reinforcing improvements in value. For example, let's take the prescription drug benefit, the big reform of today that everyone is talking about. This is... View Details
- 28 Jul 2009
- First Look
First Look: July 28
report, new CEO Hank McKinnell discusses Pfizer's performance goals and its acquisition of Pharmacia, which gave it control of the anti-arthritis drug Celebrex. In the 2005 report, McKinnell discusses his decision to keep Celebrex on the... View Details
Keywords: Martha Lagace
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman